Pharmacology & ToxicologyeLifePeer-reviewed
Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone on improving thrombocytopenia
Ling Zhou, Chengyang Ni, Ruixue Liao…·Jianming Wu
This study shows vilazodone improves thrombocytopenia by activating SRC/MAPK signaling through 5-HT1A receptor in megakaryocyte differentiation.